Want to see KR:006280 full AI Analyst Report?
GC Biopharma Corp. (006280) Stock Forecast & Price Target
006280 Analyst Ratings
There are no analyst ratings in the last 3 months.
006280 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | KRW 131,682 | hold | 1.14%Upside | Initiated | 10/28/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| OpenAI - Gpt-5.6Sol | 10/28/26 | KRW 131,682 | hold | 1.14%Upside | Initiated | TipRanks - OpenAI |
006280 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 006280 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 006280 average Analyst price target in the past 3 months is ―.
006280 Financial Forecast
006280 Earnings Forecast
Next quarter’s earnings estimate for 006280 is $169.42 with a range of ― to ―. The previous quarter’s EPS was $169.42. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
006280 Sales Forecast
Next quarter’s sales forecast for 006280 is $546.87B with a range of $517.00B to $608.00B. The previous quarter’s sales results were $421.18B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.